Article The Next 10 Years: What’s Coming for Gene Editing in the Clinic The next 10 years will likely bring gene editing to market for an array of rare conditions. However, making the potential benefits broadly available won’t be without roadblocks. Here,
Technology Networks,
With multiple biotech companies racing to bring their sickle cell gene editing treatments across the US Food and Drug…